Bahrain vs Guatemala: Access to anti-retroviral drugs, female
Bahrain
73.0%
in 2024
Guatemala
73.0%
in 2024
Bahrain rank
71st
Guatemala rank
71st
Access to anti-retroviral drugs, female over time
- Bahrain
- Guatemala
How they compare
Bahrain currently reports 73.0% against 73.0% in Guatemala, a difference of 0.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Bahrain ahead.
Bahrain ranks 71st and Guatemala ranks 71st of 141 countries.
Across the 3 decades both report, Bahrain averaged higher in 2 and Guatemala in 1.
Head to head by decade
| Decade | Bahrain | Guatemala | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 25.1% | 10.3% | 14.8% | Bahrain |
| 2010s | 56.6% | 60.2% | 3.6% | Guatemala |
| 2020s | 73.8% | 72.4% | 1.4% | Bahrain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Bahrain or Guatemala?
- Bahrain, at 73.0% against 73.0% in Guatemala as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Bahrain and Guatemala?
- 0.0%, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and Guatemala?
- 25 years are reported by both, from 2000 to 2024.
- How do Bahrain and Guatemala rank globally for access to anti-retroviral drugs, female?
- Bahrain ranks 71st and Guatemala ranks 71st of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.